Oversold

INVA

Valuation45/ 100
Cash flow & growth85/ 100
Upside potential37/ 100
Risk potential29/ 100

INVA's valuation appears fair while strong fundamentals support the investment case and weaker than expected earnings are holding it back, though analyst coverage is limited and estimates vary widely.

Score change since last week

The score rose 2 points, mainly due to valuation and price changes. Price rose 1.7%, from $20.97 to $21.33.

Valuation and price changes added 2.5 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Estimated operating-earnings valuation: current PE is 25x versus 17.2x in comparable estimated history. The model caps earnings at operating profit after interest, assuming proportional tax and per-share effects. This is an estimate, not a verified investment-gain adjustment.

Reported EPS and PE remain in the valuation table. The same estimate is applied to historical earnings and eligible price scenarios. Its contribution to the score is limited by the available evidence; it does not identify all non-recurring items. Comparable history: 31 weeks.

Cash flow & growth

Business trends are strong. Over the past year: revenue +19.8%, operating margin +35.9 percentage points. Free cash flow is 42.5% of revenue. The business score is 84.6/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $1.00 of EPS and a 23.9× PE, suggesting a share price of about $23.90 — 15% above today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $0.69 of EPS and a 21.3× PE, suggesting a share price of about $14.78 — 29% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

INVA vs Historical averages

MetricCurrentAverageRelative
PE5x9.3x46% lower
PE percentile295042% lower
EPS$4.10$2.3972% higher
FCF$188.3M$224M16% lower
Loading historical comparisons…

INVA’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.

INVA Forward outlook

MetricOutlook
Forward valuationStrongly deteriorating
Forward earningsStrong decline
Forward revenueGrowth
Forward profitabilityStrongly contracting
Analyst coverageLimited
Estimate dispersionWide

INVA’s outlook is mixed, with weaker expected earnings weighing on the picture.

INVA PE Valuation

Loading pe valuation table…

This table applies INVA's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

INVA Earnings Per Share

Loading earnings per share…

This chart tracks INVA's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

INVA Quarterly Revenue

Loading quarterly revenue…

This chart tracks INVA's quarterly revenue over time and shows how sales are changing from year to year.

INVA Free Cash Flow

Loading free cash flow…

This chart tracks INVA's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

INVA Total Shares

Loading shares over time…

This chart tracks changes in INVA's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

INVA Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

INVA PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares INVA's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

INVA Weekly Price

Loading weekly price…

This chart uses INVA's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

INVA Weekly Moving Averages

Loading weekly moving averages…

This chart compares INVA's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

INVA Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.